Concluded targeted enrollment of Phase 3 INDIGO trial evaluating obexelimab for the treatment of Immunoglobulin G4-Related ...
an alternative to a more traditional initial public offering that doesn’t require as rigorous financial disclosures as an ...
William Blair & Company, L.L.C., Barclays Capital Inc. and TD Securities (USA) LLC are acting as joint book-running managers for the offering. Craig-Hallum Capital Group LLC, Roth Capital Partners, ...
If the grey market premium is any indication, Swiggy's shares could list close to its issue price of Rs 390 per share, ...
Rosmerta Digital Services is looking to raise over ₹206 crore through an initial public offering (IPO), which will open for ...
This is as per a report by Bloomberg citing people familiar with the development. If successful, this IPO could become one of ...
The firm which is backed by investors such as Peak XV Partners and Lightspeed India Partners, has so far raised $698 million ...
Bursa Malaysia Bhd is experiencing a resurgence in initial public offerings (IPOs) as 2024 draws to a close, reflecting ...
Kuching-based contractor Hartanah Kenyalang Bhd, which seeks to list on the ACE Market, plans to use the proceeds raised to ...